nodular lymphocyte-predominant Hodgkin lymphoma

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instance_of gptkb:Oncology
gptkbp:associated_with Reed-Sternberg cells
gptkbp:can_be_used_to weight loss
fever
night sweats
itching skin
gptkbp:can_detect PET scan
gptkbp:can_lead_to lymphadenopathy
hepatomegaly
splenomegaly
gptkbp:characterized_by nodular lymphocyte predominance
gptkbp:diagnosis clinical evaluation
biopsy
generally favorable
immunohistochemistry
gptkbp:first_described_by gptkb:1980s
gptkbp:has_type gptkb:Oncology
https://www.w3.org/2000/01/rdf-schema#label nodular lymphocyte-predominant Hodgkin lymphoma
gptkbp:is_associated_with gptkb:non-Hodgkin_lymphoma
chronic inflammation
EBV infection
lymphocyte activation
B symptoms
lymphocyte depletion
gptkbp:is_characterized_by lymphocyte predominance
lymphocyte-rich infiltrate
nodular lymphocyte-rich areas
nodular patterns
preservation of lymphocyte architecture
gptkbp:is_common_in gptkb:classical_Hodgkin_lymphoma
young adults
males
gptkbp:is_considered a distinct entity from classical Hodgkin lymphoma
a lymphoproliferative disorder
a rare form of lymphoma
gptkbp:is_linked_to environmental factors
genetic factors
viral infections
gptkbp:is_managed_by hematologists
gptkbp:is_noted_for better prognosis than classical Hodgkin lymphoma
gptkbp:is_part_of hematologic malignancies
Hodgkin lymphoma spectrum
lymphoma category
gptkbp:is_related_to immune system disorders
gptkbp:is_studied_for treatment outcomes
gptkbp:is_studied_in clinical trials
gptkbp:may_be_treated_with stem cell transplant
gptkbp:may_relapse_after treatment
gptkbp:may_require_follow_up after treatment
gptkbp:occurs_in autoimmune diseases
lymphatic system
gptkbp:requires gptkb:surgery
gptkbp:scientific_classification indolent lymphoma
gptkbp:symptoms swollen lymph nodes
gptkbp:treatment gptkb:immunotherapy
radiotherapy
radiation therapy
chemotherapy
oncologists
targeted therapy
gptkbp:bfsParent gptkb:Hodgkin's_lymphoma
gptkbp:bfsLayer 7